Research News   |   Drug News   |   Conference News


Leveraging Crowdsourcing: Arch2POCM Meeting Report
July 22, 2011
A new initiative led by Sage Bionetworks challenges the old paradigms, seeking to innovate drug discovery and development with a crowdsourcing twist. The meeting report, available from Science Translational Medicine, discusses their new model for precompetitive clinical validation of putative disease targets via a public-private partnership.


Report on the ICSCN Workshop on Progress towards Clinical Trials using Stem Cells for ALS/MND
July 19, 2011
Defining the problem is the first step towards creating viable solutions. At a workshop held in NYC in January 2011 co-sponsored by ALSA and MNDA, ALS and stem cell researchers gathered to assess where we are and where we need to go towards realizing the enormous potential of stem cells for future ALS cellular therapies and drug development purposes. Several major roadblocks were identified that covered the gamut from basic research to preclinical to clinical challenges facing ALS stem cell studies.


ALS in California: A Report from the First Annual California ALS Research Summit
July 1, 2011


Orphan Drug Discovery, Risky or Right? Part II: Highlights from the Neurotech 2011 Conference
June 8, 2011
Is the current pharma focus on orphan diseases, defined by FDA as those affecting fewer than 200,000 individuals in the United States, simply a passing fad, the so-called "disease du jour”, or do they represent an important new area of innovation for the biomedical industry?


Blood Brain Barrier: Across the Great Divide: Part I: Highlights of Neurotech 2011 Conference
June 8, 2011
Prize4Life recently attended the annual Neurotechnology Industry Organization (NIO) Annual Neurotech Meeting in San Francisco. While there were many provocative sessions, two stand out as having particular relevance to ALS, included this piece on exciting progress in CNS delivery.